<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Deep Learning-Based Regional White Matter Hyperintensity Mapping as a Robust Biomarker for Alzheimer's Disease - Health AI Hub</title>
    <meta name="description" content="This paper introduces a deep learning framework for segmenting and localizing white matter hyperintensities (WMH) within specific anatomical regions, addressing">
    <link rel="icon" type="image/svg+xml" href="../favicon.svg">
    <link rel="icon" type="image/png" sizes="32x32" href="../favicon-32x32.png">
    <link rel="icon" type="image/png" sizes="16x16" href="../favicon-16x16.png">
    <link rel="stylesheet" href="../styles.css">
</head>
<body>
    <header>
        <div class="container">
            <div class="breadcrumb">
                <a href="../index.html">‚Üê Back to all papers</a>
                <a href="../index.html" class="home-btn">üè† Home</a>
            </div>
        </div>
    </header>

    <main class="container paper-detail">
        <article>
            <h1>Deep Learning-Based Regional White Matter Hyperintensity Mapping as a Robust Biomarker for Alzheimer's Disease</h1>

            <div class="paper-metadata">
                <div class="meta-row">
                    <strong>arXiv ID:</strong> <a href="http://arxiv.org/abs/2511.14588v1" target="_blank">2511.14588v1</a>
                </div>
                <div class="meta-row">
                    <strong>Published:</strong> 2025-11-18
                </div>
                <div class="meta-row">
                    <strong>Authors:</strong> Julia Machnio, Mads Nielsen, Mostafa Mehdipour Ghazi
                </div>
                <div class="meta-row">
                    <strong>Categories:</strong> cs.CV, cs.AI
                </div>
                <div class="meta-row">
                    <strong>Relevance Score:</strong> 1.00 / 1.00
                </div>
            </div>

            <div class="action-buttons">
                <a href="http://arxiv.org/abs/2511.14588v1" target="_blank" class="btn btn-primary">View on arXiv</a>
                <a href="https://arxiv.org/pdf/2511.14588v1" target="_blank" class="btn btn-primary">Download PDF</a>
            </div>

            <section class="paper-section">
                <h2>Summary</h2>
                <p class="summary-text">This paper introduces a deep learning framework for segmenting and localizing white matter hyperintensities (WMH) within specific anatomical regions, addressing the limitation of previous methods that only provide global lesion load. The study demonstrates that regional WMH quantification significantly outperforms global lesion burden for Alzheimer's disease (AD) classification, especially when integrated with brain atrophy metrics, offering a more robust biomarker for neurodegenerative disorders.</p>
            </section>

            <section class="paper-section">
                <h2>Medical Relevance</h2>
                <p>Accurate and localized quantification of white matter hyperintensities provides a more sensitive and specific imaging biomarker for Alzheimer's disease than global measures, potentially enabling earlier and more precise diagnosis, prognosis, and therapeutic monitoring in neurodegenerative disorders.</p>
            </section>

            
            <section class="paper-section">
                <h2>AI Health Application</h2>
                <p>The AI application is a deep learning framework designed for automated segmentation and regional localization/quantification of white matter hyperintensities (WMH) from brain MRI scans. This framework aims to provide more granular and diagnostically valuable information than global WMH measures, ultimately enhancing the early diagnosis, prognosis, and stratification of patients with Alzheimer's disease and other neurodegenerative disorders.</p>
            </section>
            

            <section class="paper-section">
                <h2>Key Points</h2>
                <ul class="key-points">
                    
                    <li>A deep learning framework is proposed for robust WMH segmentation and localization, evaluated across public datasets and an independent ADNI cohort.</li>
                    
                    <li>The predicted lesion loads from the model are consistent with reference WMH estimates, confirming robustness across variations in lesion load, acquisition, and demographics.</li>
                    
                    <li>Regional WMH volumes, quantified within anatomically defined brain regions, consistently outperform global lesion burden for AD diagnostic classification.</li>
                    
                    <li>Integrating regional WMH metrics with brain structure volumes (atrophy markers) further enhances classification performance, achieving AUC values up to 0.97.</li>
                    
                    <li>Specific spatially distinct white matter regions, particularly within anterior tracts, are reproducibly identified as associated with AD diagnostic status, suggesting localized vulnerability.</li>
                    
                    <li>The research highlights the added diagnostic value of understanding the spatial distribution of WMH rather than just their total volume.</li>
                    
                    <li>The findings suggest that incorporating localized WMH alongside atrophy markers could significantly improve early diagnosis and stratification in neurodegenerative disorders.</li>
                    
                </ul>
            </section>

            <div class="two-column">
                <section class="paper-section">
                    <h2>Methodology</h2>
                    <p>The study employs a deep learning framework for WMH segmentation and subsequent localization into anatomically defined regions. The methodology involves quantifying WMH load within these regions and combining these regional measures with brain structure volumes (atrophy metrics). Evaluation was conducted using public datasets and an independent Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort, assessing robustness to variations and diagnostic classification performance using AUC.</p>
                </section>

                <section class="paper-section">
                    <h2>Key Findings</h2>
                    <p>The deep learning model provides robust WMH segmentation. Regional WMH volumes consistently outperform global lesion burden for AD classification. Integration of regional WMH with brain atrophy metrics substantially improves diagnostic performance, reaching AUCs up to 0.97. Several spatially distinct regions, especially in anterior white matter tracts, are reproducibly linked to AD diagnostic status.</p>
                </section>
            </div>

            <section class="paper-section">
                <h2>Clinical Impact</h2>
                <p>This research offers a potential paradigm shift in using WMH as a biomarker by moving beyond global load to precise regional quantification. This could lead to enhanced early diagnosis, improved patient stratification, and better tracking of disease progression or treatment response in Alzheimer's disease and other neurodegenerative conditions.</p>
            </section>

            
            <section class="paper-section">
                <h2>Limitations</h2>
                <p>The abstract does not explicitly state limitations of the study or method. However, typical limitations for such studies might include generalizability to diverse populations or specific scanner types not included in the validation datasets, and the need for prospective validation in clinical settings.</p>
            </section>
            

            
            <section class="paper-section">
                <h2>Future Directions</h2>
                <p>The paper suggests that incorporating localized WMH metrics alongside existing atrophy markers holds promise for enhancing early diagnosis and stratification in various neurodegenerative disorders, implying a direction towards clinical implementation and further validation.</p>
            </section>
            

            <section class="paper-section">
                <h2>Medical Domains</h2>
                <div class="tags">
                    
                    <span class="tag">neurology</span>
                    
                    <span class="tag">geriatrics</span>
                    
                    <span class="tag">radiology</span>
                    
                    <span class="tag">neuroscience</span>
                    
                    <span class="tag">dementia research</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Keywords</h2>
                <div class="tags">
                    
                    <span class="tag tag-keyword">white matter hyperintensities</span>
                    
                    <span class="tag tag-keyword">deep learning</span>
                    
                    <span class="tag tag-keyword">Alzheimer's disease</span>
                    
                    <span class="tag tag-keyword">biomarker</span>
                    
                    <span class="tag tag-keyword">regional analysis</span>
                    
                    <span class="tag tag-keyword">neuroimaging</span>
                    
                    <span class="tag tag-keyword">segmentation</span>
                    
                    <span class="tag tag-keyword">classification</span>
                    
                </div>
            </section>

            <section class="paper-section">
                <h2>Abstract</h2>
                <p class="abstract">White matter hyperintensities (WMH) are key imaging markers in cognitive aging, Alzheimer's disease (AD), and related dementias. Although automated methods for WMH segmentation have advanced, most provide only global lesion load and overlook their spatial distribution across distinct white matter regions. We propose a deep learning framework for robust WMH segmentation and localization, evaluated across public datasets and an independent Alzheimer's Disease Neuroimaging Initiative (ADNI) cohort. Our results show that the predicted lesion loads are in line with the reference WMH estimates, confirming the robustness to variations in lesion load, acquisition, and demographics. Beyond accurate segmentation, we quantify WMH load within anatomically defined regions and combine these measures with brain structure volumes to assess diagnostic value. Regional WMH volumes consistently outperform global lesion burden for disease classification, and integration with brain atrophy metrics further improves performance, reaching area under the curve (AUC) values up to 0.97. Several spatially distinct regions, particularly within anterior white matter tracts, are reproducibly associated with diagnostic status, indicating localized vulnerability in AD. These results highlight the added value of regional WMH quantification. Incorporating localized lesion metrics alongside atrophy markers may enhance early diagnosis and stratification in neurodegenerative disorders.</p>
            </section>

            
            <section class="paper-section">
                <h2>Comments</h2>
                <p>Accepted at SPIE - Medical Imaging Conference 2026</p>
            </section>
            

            
        </article>
    </main>

    <footer class="container">
        <p><a href="../index.html">‚Üê Back to all papers</a></p>
    </footer>
</body>
</html>